Supplementary MaterialsSupplement. progression-free and general survival in patients with CTCL, and MF in particular. In early-stage patients, a TCF 25% in skin had a higher HR for PFS than any other established prognostic factor (stage IB versus IA, presence of plaques, high blood lactate dehydrogenase concentration, large-cell transformation, or age group). The TCF is a… Continue reading Supplementary MaterialsSupplement. progression-free and general survival in patients with CTCL, and